Giles Kerr, ACA

Investors

Board and leadership

Key to committees/roles:

E Executive
N Nomination
A Audit and Risk
R Remuneration
Chair

Non-Executive Director and Senior Independent Director

Appointment: 12 December 2018

Background: Giles has substantial commercial and financial experience from service on numerous public and private company boards and as an audit partner. From 1990 he served in a variety of increasingly senior roles at Amersham plc, including as Chief Financial Officer and a Board member from 1997 to 2004, when the company was acquired by GE Healthcare. Prior to his role at Amersham, he was a National Partner with Arthur Andersen. He was Director of Finance of the University of Oxford from 2005 until 2018 and was previously a Director of Victrex plc, BTG plc, Quanta Dialysis Technologies, Elan Corporation Inc and Adaptimmune plc.

Current external appointments: Giles is currently Chairman of PayPoint plc, as well as a Non-Executive Director of Arix Bioscience plc, Senior plc and a number of smaller private companies.

Skills, experience and contribution: A Fellow of the Institute of Chartered Accountants of England and Wales with over 20 years’ experience in key senior positions in a number of companies, Giles has played a pivotal role their development and growth. Giles brings his first-hand understanding of Abcam’s academic research customers from his time at Oxford University.

Board & Leadership

Investors

Giles Kerr, ACA

Appointment: 12 December 2018

VIEW PRODUCTS

Statements